Baxter Reports First-Quarter 2024 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
- Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
- Regardless of the selected path, Baxter currently expects the separation of its Kidney Care business to take place in the second half of 2024.
- For full-year 2024: Baxter now expects sales growth of approximately 2% on a reported basis and 2% to 3% on a constant currency basis.
- A webcast of Baxter’s first-quarter 2024 conference call for investors can be accessed live from a link in the Investor Relations section of the company’s website at www.baxter.com beginning at 7:30 a.m. CDT on May 2, 2024.